# OnCo record paper-marquart-genome-driven-oncology-benefit-jama-oncol-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-marquart-genome-driven-oncology-benefit-jama-oncol-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-marquart-genome-driven-oncology-benefit-jama-oncol-2018" ;
  schema:name "Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology"@en ;
  schema:description "Counting every drug approved for a gene change up to January 2018, about 8 in 100 Americans with advanced cancer were eligible for one and about 5 in 100 were estimated to benefit."@en ;
  schema:url <https://onco.cc/key-papers/paper-marquart-genome-driven-oncology-benefit-jama-oncol-2018/> ;
  schema:dateModified "2026-10-20"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2018.1660>, <https://pubmed.ncbi.nlm.nih.gov/29710180/> ;
  onco:tag "precision" ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2018.1660> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Marquart J, Chen EY, Prasad V" ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/cgp/> ;
  onco:terms <https://onco.cc/terms/cancer-drivers-vs-actionable/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .